- Statement of Changes in Beneficial Ownership (4)
September 04 2012 - 4:35PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
READING CHRISTOPHER J
|
2. Issuer Name
and
Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV
[
USPH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Chief Executive Officer
|
(Last)
(First)
(Middle)
1300 W. SAM HOUSTON PKWY S., SUITE 300
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/30/2012
|
(Street)
HOUSTON, TX 77042
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
8/30/2012
|
|
M
|
|
100000
|
A
|
$13.54
|
163323
(1)
|
D
|
|
Common Stock
|
8/30/2012
|
|
F
|
|
49907
|
D
|
$27.13
(2)
|
113416
(1)
|
D
|
|
Common Stock
|
8/31/2012
|
|
S
|
|
21556
|
D
|
$26.02
(3)
|
91860
(1)
|
D
|
|
Common Stock
|
9/4/2012
|
|
S
|
|
28537
|
D
|
$26.38
(4)
|
63323
(1)
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Director's Stock Option Right to Buy
|
$13.54
|
8/30/2012
|
|
M
|
|
|
100000
|
8/30/2012
|
10/5/2014
|
Common Stock
|
100000
|
$0.00
(5)
|
50000
|
D
|
|
Explanation of Responses:
|
(
1)
|
Includes 18,750 restricted shares in which restrictions lapse in equal quarterly installments of 1,875 shares with the next installment on September 30, 2012 and the last on December 31, 2014. Also, includes 20,214 shares of common stock granted as restricted stock. Restrictions lapse in equal quarterly installments of 1,443 shares with the next installment on September 30, 2012, and the final installment of 1,455 shares on December 31, 2015.
|
(
2)
|
Surrender of shares in connection with cashless exercise
|
(
3)
|
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00- $26.29, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
|
(
4)
|
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00- $26.99, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
|
(
5)
|
Granted pursuant to the Company's 2003 Stock Incentive Plan, which complies with Rule 16b-3.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
READING CHRISTOPHER J
1300 W. SAM HOUSTON PKWY S.
SUITE 300
HOUSTON, TX 77042
|
X
|
|
Chief Executive Officer
|
|
Signatures
|
/s/Christopher J Reading
|
|
9/4/2012
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Jul 2023 to Jul 2024